FDA Inspection 1109982 — Southern Blood Services Inc

Southern Blood Services Inc — FEI 3002597075

The FDA completed an inspection of Southern Blood Services Inc on November 15, 2019 in Nashville, TN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 15, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Nashville, TN (United States)

Citations

IDCFRDescription
1809721 CFR 630.10(h)Ineligible Donor
9421 CFR 606.100(b)(15)Schedules and procedures for equipment & calibration